ARNA - Arena Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.19B
Enterprise Value 31.64B
Trailing P/E N/A
Forward P/E 1-12.92
PEG Ratio (5 yr expected) 10.75
Price/Sales (ttm)102.39
Price/Book (mrq)3.76
Enterprise Value/Revenue 376.38
Enterprise Value/EBITDA 6-19.11

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-418.80%

Management Effectiveness

Return on Assets (ttm)-13.60%
Return on Equity (ttm)-34.20%

Income Statement

Revenue (ttm)21.43M
Revenue Per Share (ttm)0.58
Quarterly Revenue Growth (yoy)5.70%
Gross Profit (ttm)-49.65M
EBITDA -85.64M
Net Income Avi to Common (ttm)-103.56M
Diluted EPS (ttm)-2.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)629.12M
Total Cash Per Share (mrq)12.78
Total Debt (mrq)60.79M
Total Debt/Equity (mrq)10.41
Current Ratio (mrq)15.28
Book Value Per Share (mrq)11.86

Cash Flow Statement

Operating Cash Flow (ttm)-80.17M
Levered Free Cash Flow (ttm)-61.18M

Trading Information

Stock Price History

Beta 2.80
52-Week Change 391.35%
S&P500 52-Week Change 313.73%
52 Week High 350.05
52 Week Low 316.95
50-Day Moving Average 346.49
200-Day Moving Average 340.25

Share Statistics

Avg Vol (3 month) 3858.48k
Avg Vol (10 day) 3798.17k
Shares Outstanding 549.23M
Float 49.11M
% Held by Insiders 10.26%
% Held by Institutions 180.08%
Shares Short (Jun 15, 2018) 43.18M
Short Ratio (Jun 15, 2018) 44.86
Short % of Float (Jun 15, 2018) 47.25%
Short % of Shares Outstanding (Jun 15, 2018) 46.46%
Shares Short (prior month May 15, 2018) 42.97M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/10
Last Split Date 3Jun 19, 2017